Wedbush Starts Rockwell Collins (COL) at Outperform; Commercial Recovery To Drive Sentiment
Tweet
Share
E-mailGet Alerts COL Hot Sheet
Price: $141.04 --0%
Rating Summary:
5 Buy, 17 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Rating Summary:
5 Buy, 17 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 6
Join SI Premium – FREE
Wedbush initiates coverage on Rockwell Collins (NYSE: COL) with an Outperform. PT $71.
Wedbush analyst said, "We believe Rockwell Collins represents a play on the commercial aerospace recovery, where above-industry growth will be driven by recent market share gains...We believe we are not too early to highlight Rockwell Collins as a way to play the business jet recovery...Historically higher levels of R&D spending have enabled market share gains, which should enable Rockwell Collins to outgrow the broader commercial markets...Our fiscal 2011, 2012 and 2013 EPS estimates are $4.11, $4.75 and $5.26, respectively."
For more ratings news on Rockwell Collins click here and for the rating history of Rockwell Collins click here.
Shares of Rockwell Collins closed at $62.02 yesterday.
Wedbush analyst said, "We believe Rockwell Collins represents a play on the commercial aerospace recovery, where above-industry growth will be driven by recent market share gains...We believe we are not too early to highlight Rockwell Collins as a way to play the business jet recovery...Historically higher levels of R&D spending have enabled market share gains, which should enable Rockwell Collins to outgrow the broader commercial markets...Our fiscal 2011, 2012 and 2013 EPS estimates are $4.11, $4.75 and $5.26, respectively."
For more ratings news on Rockwell Collins click here and for the rating history of Rockwell Collins click here.
Shares of Rockwell Collins closed at $62.02 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
